---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-022827"
form_type: "8-K"
ticker: "VERA"
cik: "0001831828"
company_name: "Vera Therapeutics, Inc."
filed_at: "2023-02-02T23:59:59+00:00"
generated_at: "2026-06-20T02:41:57.178699+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Vera Therapeutics announces $100M follow-on public offering of 14.3M shares at $7.00/share

## Summary
- Underwriting agreement signed for 14,285,715 shares of Class A common stock at $7.00 per share.
- Gross proceeds of approximately $100 million before underwriting discounts and offering expenses.
- Closing expected February 6, 2023; underwriters have 30-day option for 2,142,857 additional shares.
- Lead underwriters: J.P. Morgan, Cowen, and Evercore.

## SEC filing metadata
- accession: 0001193125-23-022827
- form_type: 8-K
- ticker: VERA
- cik: 0001831828
- company_name: Vera Therapeutics, Inc.
- filed_at: 2023-02-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831828/000119312523022827/0001193125-23-022827-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831828/000119312523022827/d456639d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-022827
- JSON: https://secwatch.observer/filing/0001193125-23-022827.json
- Plain text: https://secwatch.observer/filing/0001193125-23-022827.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.